PRRS

Porcine reproductive and respiratory syndrome (PRRS) is a viral disease that causes a decrease in reproductive performance in breeding animals and respiratory disease in pigs of any age. PRRS is the most economically significant disease affecting swine production in the world today.

 PRRS

BOEHRINGER INGELHEIM SELECTS AWARD RECIPIENTS

  • 10 minutes

Boehringer Ingelheim Vetmedica Inc., has selected four recipients of its annual Advancement in Porcine Reproductive and Respiratory Syndrome (PRRS) Research Awards.

 PRRS

EUROPEAN SCIENTISTS HONOURED FOR PCV RESEARCH

  • 10 minutes

Dr Lars Erik Larsen from the Danish National Veterinary Institute in Copenhagen, Dr Nicolas Rose from the French Agency for Food Safety in Ploufragan and Dr Gerard Wellenberg from the Dutch Animal Health Service in Deventer are the winners of this year's European Porcine Circovirus Research Award.

 PRRS

BOEHRINGER DONATES PRRS RISK ASSESSMENT PROGRAM TO INDUSTRY

  • 10 minutes

Boehringer Ingelheim Vetmedica, Inc., last week transferred ownership of its Risk Assessment Program for porcine reproductive and respiratory syndrome (PRRS) to the American Association of swine Veterinarians (AASV).

It can be of your interest
SIGNS OF HYPOGALACTIA
Others

SIGNS OF HYPOGALACTIA

  • 5 minutes

Hypogalactia is likely to result in malnutrition of suckling pigs.

 Others

METACAM FOR PIGS NOW AVAILABLE AS ORAL SUSPENSION

  • 5 minutes

Boehringer Ingelheim’s market leading Animal Health medication Metacam® (active ingredient: Meloxicam) obtained EU wide marketing authorisation as an oral suspension in a concentration of 15 mg/ml for use in pigs.

 PRRS

2016 EUROPEAN PRRS RESEARCH AWARD: CALLS FOR SUBMISSIONS UNTIL JULY 1ST

  • 10 minutes

Ingelheim, Germany, 15 March 2016 –

For the third time, Boehringer Ingelheim Animal Health sponsors the European PRRS Research Award to support applied research for improved control of the swine disease PRRS (Porcine Reproductive and Respiratory Syndrome). Research proposals for the 2016 European PRRS Research Award can be submitted until July 1st, 2016. Boehringer Ingelheim Animal Health will provide three grants of 25,000 euros each to fund research proposals that will generate new and relevant data to better understand this devastating and costly disease.